Full-Time

National Key Account Manager

Pharma

Posted on 9/24/2025

Celgard

Celgard

201-500 employees

High-performance membranes for energy storage

Compensation Overview

$190k - $230k/yr

Western United States, USA

Remote

Candidates must reside within close range of a major airport in the Western United States.

Category
Sales & Account Management (1)
Requirements
  • BS/BA from an accredited institution; MA, a plus.
  • Minimum of 5 years’ experience as a Transplant Account Manager, with a proven history of success in transplant patient journey.
  • Intermediate to expert level knowledge in a disease state and professional field (transplantation).
  • Excellent written and verbal communication skills; communicates in a respectful tone and manner.
  • Demonstrated ability to align with cross-functional teams to provide solutions to customers’ needs and to create or expand opportunities.
  • Experienced in presenting to healthcare practitioners on Company’s product(s).
  • Ability to lead without authority on projects and regional area objectives.
  • Promotes cooperation with other departments.
  • Stays abreast of business, industry, and market information that may reveal business opportunities.
  • Responds to customers’ needs through planned and personalized communication in a compliant manner in order to support the customer and ensure satisfaction.
  • Proficient in MS Office Suite and Adobe Pro.
  • Travel Requirements: 2.5 nights per week, for purposes of oversight of the incumbent’s designated region.
Responsibilities
  • Understands the dynamics of the assigned national account’s approaches to kidney transplant.
  • Becomes SME on how each assigned account operates as a year-one care model for follow-up of 30, 60, 90, and 120 days for each newly transplanted kidney patient.
  • Provides strategic on-label insights and recommendations to Transplant Account Managers (TAM) and Regional Sales Directors (RSD) on tactical approaches.
  • Understands the national account approach with protocol decision-making and identifies the stakeholders involved in national account protocol creation and full adoption (P&T and members involved in decision-making).
  • Provides compliant oversight, management, and communication for 340B tiered contractual agreements with target accounts.
  • Provides compliant oversight, management, and communication for Non-340B GPO target accounts including understanding national system structures, customer relationship building, and compliant transparency around pricing and discounts.
  • Provides compliant oversight, management, and communication for VA/DoD target accounts inclusive of protocols, pricing, and customer relationship.
  • Conducts interactions with target customers in accordance with laws, rules, regulations and Company policies and procedures.
  • Clinically educates each protocol stakeholder and/or formulary P&T member to drive adoption of Envarsus as standard of care using materials approved by Veloxis.
  • Monitors inpatient Envarsus sales to identify trends.
  • Shares and verifies the accuracy of inpatient purchasing processes and pricing with accounts.
  • Identifies care models for each assigned national account and learns the 'why'/'what' of protocol enforcement and 'how' protocols are followed by internal and external care model practitioners.
  • Gains an understanding as to how a national system and its centers determine a protocol and develops a consistent approach for working towards obtaining protocol placement at such centers.
  • Works in harmony with Veloxis’s Regional Sales Directors and understands etiquette that yields the best teamwork, gaining alliance on call approach with assigned TAMs and ensuring no disruption of the account call cycle.
  • Provides reasonably accurate formulary and protocol forecasts monthly, quarterly, and annually.
  • Conducts 340B account business reviews for tiered agreements, inclusive of visibility and transparency around pricing/discounts.
  • Conducts interactions with Non-340B GPO customers for strategic oversight of customer system, management of discounts, and maintaining customer relationships.
  • Conducts interactions with VA/DoD to support protocol adoption, pricing/discounts, and customer relationship management.
  • Conducts all interactions with any healthcare provider or practitioner, including any member of a center’s P&T committee, as well as any government official, in accordance with all applicable laws, regulations, and Veloxis policies and procedures.
Desired Qualifications
  • MA, a plus.

Celgard makes and sells high-performance membrane materials and thin separators used inside batteries, as well as fabrics for outdoor apparel and medical PPE. The membranes sit between battery electrodes to prevent contact while allowing ions to pass, enabling safe and efficient operation in lithium-ion and other chemistries. The company stands out through its Asahi Kasei Group affiliation and strategic alliances (such as with Æsir Technologies) to pursue new battery chemistries, while expanding manufacturing capacity. Its goal is to provide reliable membranes and protective fabrics at scale to support safer, longer-lasting energy storage and protective textiles, and to drive industry growth through collaborations.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Charlotte, North Carolina

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Charlotte plant expansion adds 100 jobs, boosts LIB separator capacity for EVs.
  • Asahi Kasei invests in Hipore wet-process coating lines at Charlotte site.
  • Proven separators serve CATL, Panasonic in high-performance EV, ESS applications.

What critics are saying

  • CATL's in-house separators capture 39% EV market, cut Celgard revenue 10-15% by 2027.
  • SK Innovation, Toray wet-process tech displaces dry-process, erodes share in 12 months.
  • Solid-state batteries from Toyota, QuantumScape eliminate separators by 2028.

What makes Celgard unique

  • Celgard specializes in solvent-free dry-process microporous membranes for lithium-ion batteries.
  • Global facilities in USA, China anchor manufacturing for EV battery separators.
  • Strategic alliances with Æsir, Lithion, C4V target Ni-Zn, LFP, BM-LMP batteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

Yahoo Finance
Jan 29th, 2024
Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Together, Celgard and Æsir will collaborate on joint research projects to further develop high-technology next-generation Nickel-Zinc (Ni-Zn), Zinc-Air (Zn-Air), Lithium-Zinc (Li-Zn) and Sodium-Zinc (Na-Zn) batteries used primarily in aviation, data centers, telecom, energy infrastructure and electric vehicle (EV) charging applications.

Plant Services
Nov 30th, 2023
Celgard expands North Carolina manufacturing plant to support electric vehicle supply chain

Celgard, LLC has announced plans to expand its manufacturing facility in Charlotte, North Carolina, generating 100 new jobs in the process.

PR Newswire
Oct 31st, 2023
Celgard Charlotte Manufacturing Facility To Expand Battery Separator Capacity And Create New Jobs

Celgard to expand facilities, workforce and product portfolio to better serve the EV battery separator supply chain. Post thisThe Biden-Harris Administration and the U.S. Department of Energy (DOE) have identified the domestic U.S. battery market as a critical supply chain focus area for the nation. Investments in Celgard's Charlotte plant will allow the company to expand existing infrastructure to quickly meet demand of the lithium-ion battery (LIB) separator supply chain and domestic customers.Celgard manufactures dry-process membrane separator also used in vehicle electrification. The company already has a skilled employee base capable of applying technical coatings to base film shipped from Hipore™ sister locations and completing finishing steps required to meet customer specifications

Tamarindo
Jun 13th, 2023
Celgard & Lithion Battery form battery storage alliance | Tamarindo

US-headquartered Celgard, a subsidiary of Polypore International, has formed a strategic alliance with Lithion Battery, whereby the two companies will undertake joint development of battery separators for lithium-ion cells for energy storage systems and microgrids.

PR Newswire Asia
Jun 7th, 2023
Celgard Takes Another Step In Energy Storage Growth As It Forms Strategic Alliance With Lithion Battery For Next-Generation Battery Cells

CHARLOTTE, N.C., June 7, 2023 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), is pleased to announce a newly formed strategic alliance with Lithion Battery, Inc. (Lithion), whereby the two companies will undertake joint development of battery separators for next generation lithium-ion cells with Lithium Iron Phosphate (LFP) cathode material. Through this collaborative effort, the companies will meet the ever-growing demand of supplying consistent power to those in need with energy storage systems (ESS) for uses such as micro-grid power applications. The cells could also be deployed in medical tools and military and industrial markets, where Celgard has been providing separator solutions for decades.

INACTIVE